Disclosure statement
JL has served on advisory boards for Mayne Pharma, MSD, Amgen, Gilead and BMS, unrelated to this current work. DCMK has served on advisory boards for Becton Dickinson Pty Ltd and Merck Sharp & Dohme (MSD), and received financial support from MSD and F2G, unrelated to the current work. SAP receives research support from Global Life Technologies, Inc., and participated in research trials with Chimerix, Inc and Merck & Co unrelated to this current work. He participated in a clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (U01-AI132004). MG has served on advisory boards for Amgen, Pfizer, MSD, Servier and Jazz Pharmaceuticals and has received clinical trial and research support from Amgen and Servier unrelated to this current work. MAS, JO, SC-AC, and CL have no relevant COIs. No potential conflict of interest was reported by the author(s).